We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · May 25, 2021

Long-Term Overall Survival and Safety With Atezolizumab in Patients With Platinum-Treated Locally Advanced or Metastatic Urothelial Carcinoma

European Urology

 

Additional Info

European Urology
Atezolizumab Versus Chemotherapy in Patients With Platinum-Treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-Term Overall Survival and Safety Update From the Phase 3 IMvigor211 Clinical Trial
Eur Urol 2021 Apr 23;[EPub Ahead of Print], MS van der Heijden, Y Loriot, I Durán, A Ravaud, M Retz, NJ Vogelzang, B Nelson, J Wang, X Shen, T Powles

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading